Publications

Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?.

D Freire, I; L Fielding, K; A J Moore, D;

2023

PloS one, (2023).18 5 10.1371/journal.pone.0286306.

The effect of internal displacement due to armed conflict on tuberculosis treatment outcomes in northwest Syria, 2019-2020.

Daif, A; GLAZIK, R; CHECCHI, F; KHAN, P;

2023

Journal of Migration and Health, (2023).8, 10.1016/j.jmh.2023.100195.

Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.

Reid, M; Agbassi, YJ P; Arinaminpathy, N; Bercasio, A; Bhargava, A; Bhargava, M; Bloom, A; Cattamanchi, A; Chaisson, R; Chin, D; Churchyard, G; Cox, H; Denkinger, CM; Ditiu, L; Dowdy, D; Dybul, M; Fauci, A; Fedaku, E; Gidado, M; Harrington, M; Hauser, J; Heitkamp, P; Herbert, N; Herna Sari, A; Hopewell, P; ... Goosby, E.

2023

Lancet (London, England), (2023).402 10411 10.1016/s0140-6736(23)01379-x.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;

2023

PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.

Data supporting "Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of tuberculosis in two South African provinces: analysis of a cluster-randomised trial".

Carter, N; WEBB, E; Lebina, L; Motsomi, K; Bosch, Z; Martinson, N; MacPherson, P;

2023

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2023). 10.17037/DATA.00003373.

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.

Rehal, S; Cro, S; Phillips, PP; FIELDING, K; CARPENTER, JR;

2023

Clinical trials (London, England), (2023).20 5 10.1177/17407745231176773.

Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection.

SCHWALB, A; Emery, JC; Dale, KD; HORTON, KC; Ugarte-Gil, CA; HOUBEN, RM G J;

2023

American journal of epidemiology, (2023).192 12 10.1093/aje/kwad028.

Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics.

Dodd, PJ; Shaweno, D; KU, C-C; Glaziou, P; Pretorius, C; HAYES, RJ; MacPherson, P; Cohen, T; AYLES, H;

2023

Nature communications, (2023).14 1 10.1038/s41467-023-37314-1.

MUC5AC Genetic Variation Is Associated With Tuberculous Meningitis Cerebral Spinal Fluid Cytokine Responses and Mortality.

Sabo, MC; Thuong, NT T; Chang, X; Ardiansyah, E; Tram, TT B; Hai, HT; Nghia, HD T; Bang, ND; Dian, S; Ganiem, AR; Shaporifar, S; Kumar, V; Li, Z; HIBBERD, M; Khor, CC; Thwaites, GE; Heemskerk, D; Van Laarhoven, A; Van Crevel, R; Dunstan, SJ; Shah, JA;

2023

The Journal of infectious diseases, (2023).228 3 10.1093/infdis/jiad050.

The prevalence of tuberculosis infection among foreign-born Canadians: a modelling study.

Jordan, AE; Nsengiyumva, NP; HOUBEN, RM G J; Dodd, PJ; Dale, KD; Trauer, JM; Denholm, JT; Johnston, JC; Khan, FA; Campbell, JR; Schwartzman, K;

2023

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, (2023).195 48 10.1503/cmaj.230228.